28.10.2022 15:23:00
|
SAINT LOUIS UNIVERSITY TEAMS UP WITH QUEST DIAGNOSTICS ON ACCELERATED BACHELOR OF SCIENCE IN MEDICAL LABORATORY SCIENCE
Cutting-Edge Program to Help Fill the Dire Shortage of Behind-the-Scenes Heroes Who Perform Laboratory Testing that Informs Patient Diagnosis, Treatment
ST. LOUIS, Oct. 28, 2022 /PRNewswire/ -- A preeminent Jesuit research university and the world's leading provider of diagnostic information services are teaming up to fill a dire shortage of workers in a vital but little-known field.
Saint Louis University and Quest Diagnostics (NYSE: DGX) are partnering to launch an accelerated bachelor's degree program in medical laboratory science. The 16-month program will combine online academic courses with intensive hands-on learning and clinical experiences in Quest's Lenexa, Kansas laboratory.
"Medical laboratory scientists are the hidden heroes who help save lives every day," said Amanda Reed, Medical Laboratory Science Program director and assistant professor in the Department of Clinical Health Sciences at Saint Louis University'sDoisy College of Health Sciences.
Medical detectives
Medical laboratory scientists detect diseases ranging from COVID-19 to cancer.
Using sophisticated equipment and advanced technologies, an estimated 335,000 medical laboratory scientists across the United States perform 14 billion diagnostic tests each year to inform patients' diagnoses and treatment. This includes identifying pathogens that cause infections and abnormal blood cells that could be signs of cancer or other diseases. MLS professionals also perform glucose tests that lead to the diagnosis of diabetes, which affects an estimated 37 million Americans.
"We're excited to team up with SLU, a leader in educating the next generation of lab leaders," said Doug Hamilton, vice president, Laboratory Operations for Quest's Midwest Region. "The number of people currently pursuing a bachelor's degree in medical laboratory science will satisfy only half of the demand for these workers during the next 10 years.
One-third of our staff is currently at or above retirement age, making the need for MLS professionals even greater."
A growing need, dwindling programs
Despite performing lifesaving work and receiving great pay and benefits – the average annual salary for medical laboratory science graduates in the United States is $66,547, according to Burning Glass Technologies – these professionals are in short supply.
The field is projected to grow 17% by 2030, with about 12,600 openings for medical laboratory scientists during the next decade, according to the U.S. Bureau of Labor Statistics. At the same time, there are not enough colleges and universities investing in MLS education, Hamilton said.
A history of MLS education
SLU's collaboration with Quest is designed to fill these gaps with a rigorous program that exposes student to the inner workings of a busy medical laboratory.
SLU has a long history of educating medical laboratory scientists. The university's ground-campus MLS program in St. Louis was among the first in the nation and has achieved more than 85 years of continuous accreditation. There is a 100% job placement rate for students within six months of earning their bachelor's degree, and the program has a near-perfect pass rate on the national MLS board certification exam.
In Lenexa, students will gain analytical skills and technical expertise in clinical chemistry, medical microbiology, immunohematology, hematology and clinical immunology. After successfully completing the program, graduates will be eligible to take the national board of certification examination administered by the American Society for Clinical Pathology (ASCP).
While most patients will never see a medical laboratory scientist, Reed said these professionals' impact on patient care is profound. "We impress upon our students that behind every blood draw and nasal swab is a person," she said.
The Lenexa program is geared to those with at least 60 college credit hours or a bachelor's degree in another field. There will be three start dates per year – spring, summer and fall – beginning in 2023.
For more information, visit https://medlabscience.slu.edu/.
About Saint Louis UniversityFounded in 1818, Saint Louis University is one of the nation's oldest and most prestigious Catholic institutions. Rooted in Jesuit values and its pioneering history as the first university west of the Mississippi River, SLU offers more than 13,500 students a rigorous, transformative education of the whole person. At the core of the University's diverse community of scholars is SLU's service-focused mission, which challenges and prepares students to make the world a better, more just place.
About Quest DiagnosticsQuest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. https://www.questdiagnostics.com/
View original content:https://www.prnewswire.com/news-releases/saint-louis-university-teams-up-with-quest-diagnostics-on-accelerated-bachelor-of-science-in-medical-laboratory-science-301662409.html
SOURCE Saint Louis University
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
19.11.24 |
S&P 500-Wert Quest Diagnostics-Aktie: So viel Gewinn hätte eine Investition in Quest Diagnostics von vor einem Jahr abgeworfen (finanzen.at) | |
15.11.24 |
S&P 500-Handel aktuell: So entwickelt sich der S&P 500 aktuell (finanzen.at) | |
12.11.24 |
S&P 500-Papier Quest Diagnostics-Aktie: So viel hätte eine Investition in Quest Diagnostics von vor 10 Jahren abgeworfen (finanzen.at) | |
05.11.24 |
S&P 500-Titel Quest Diagnostics-Aktie: So viel hätten Anleger an einem Quest Diagnostics-Investment von vor 5 Jahren verdient (finanzen.at) | |
29.10.24 |
S&P 500-Titel Quest Diagnostics-Aktie: So viel hätten Anleger an einem Quest Diagnostics-Investment von vor 3 Jahren verdient (finanzen.at) | |
22.10.24 |
Schwacher Wochentag in New York: S&P 500 zum Ende des Dienstagshandels im Minus (finanzen.at) | |
22.10.24 |
S&P 500 aktuell: S&P 500 notiert im Plus (finanzen.at) | |
22.10.24 |
Schwacher Handel in New York: S&P 500 am Mittag in der Verlustzone (finanzen.at) |